METHYCLOTHIAZIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for methyclothiazide and what is the scope of freedom to operate?
Methyclothiazide
is the generic ingredient in five branded drugs marketed by Medpointe Pharm Hlc, Abbvie, Chartwell Rx, Ivax Pharms, Mylan, Norvium Bioscience, Par Pharm, Usl Pharma, Watson Labs, and Abbott, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.There are two drug master file entries for methyclothiazide.
Summary for METHYCLOTHIAZIDE
| US Patents: | 0 |
| Tradenames: | 5 |
| Applicants: | 10 |
| NDAs: | 17 |
| Drug Master File Entries: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 68 |
| Patent Applications: | 6,765 |
| DailyMed Link: | METHYCLOTHIAZIDE at DailyMed |
Medical Subject Heading (MeSH) Categories for METHYCLOTHIAZIDE
Anatomical Therapeutic Chemical (ATC) Classes for METHYCLOTHIAZIDE
US Patents and Regulatory Information for METHYCLOTHIAZIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Par Pharm | METHYCLOTHIAZIDE | methyclothiazide | TABLET;ORAL | 089135-001 | Feb 12, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Norvium Bioscience | METHYCLOTHIAZIDE | methyclothiazide | TABLET;ORAL | 087672-001 | Aug 17, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ivax Pharms | METHYCLOTHIAZIDE | methyclothiazide | TABLET;ORAL | 087913-001 | Jun 3, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mylan | METHYCLOTHIAZIDE | methyclothiazide | TABLET;ORAL | 087671-001 | Aug 17, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abbvie | ENDURON | methyclothiazide | TABLET;ORAL | 012524-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
